Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-09 Purchase |
2023-06-21 10:55 am |
Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director |
650,000 | $0.6 | $390,000 | 1,029,002 (Indirect Direct) |
View |
| 2022-02-24 Sale |
2022-02-28 11:38 am |
Chavant Capital Acquisition Corp. | CLAY | AUBERTON-HERVE ANDRE-JACQUES Director |
4,174 | $0 | $0 | 27,826 (Direct) |
View |
| 2021-03-26 Purchase |
2021-04-01 12:22 pm |
Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Chairman |
95,149 | $0 | $0 | 319,624 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-12-21 Option Award |
2023-12-26 5:56 pm |
N/A N/A |
Chavant Capital Acquisition Corp. | MOBX | AUBERTON-HERVE ANDRE-JACQUES Director |
145,335 | $10 | 714,127 (Indirect) |
View |
| 2023-12-21 Option Award |
2023-12-26 5:56 pm |
N/A N/A |
Chavant Capital Acquisition Corp. | MOBX | AUBERTON-HERVE ANDRE-JACQUES Director |
343,384 | $0 | 714,127 (Indirect) |
View |
| 2023-06-13 Conversion |
2023-06-21 10:58 am |
N/A N/A |
Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director |
186,111 | $0.6 | 1,215,114 (Indirect) |
View |
| 2021-07-15 Exercise |
2022-06-21 5:49 pm |
2020-07-26 2026-07-26 |
Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director |
59,378 | $0 | 442,883 (Direct) |
View |
| 2021-07-15 Exercise |
2022-06-21 5:49 pm |
N/A N/A |
Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director |
51,878 | $3.595 | 442,883 (Indirect) |
View |
| 2021-07-15 Exercise |
2022-06-21 5:49 pm |
N/A N/A |
Bionik Laboratories Corp. | BNKL | AUBERTON-HERVE ANDRE-JACQUES Director |
7,500 | $3.16 | 442,883 (Indirect) |
View |
Ownership |
2021-07-20 6:19 pm |
N/A N/A |
Chavant Capital Acquisition Corp. | CLAY | AUBERTON-HERVE ANDRE-JACQUES Director |
0 | $0 | 32,000 (Direct) |
View |